Skip to content
Sleep & circadian healthCohort study3 min read

Veterans with narcolepsy died more often than other sleep clinic patients over 25 years

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Mortality in narcolepsy and other sleep clinic patients: a 25-year propensity-matched VA cohort study. · Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026 · Original paper ↗

Key takeaway

In US veterans, all-cause mortality was 24.7% in type 1 narcolepsy and 29.1% in other narcolepsy, versus 15.0% in general sleep clinic patients (adjusted odds ratio 1.64 and 2.40). The groups differed in mean age and the data come from one health system, so the result may not carry over to other populations.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

Earlier work suggested people with narcolepsy die earlier than the general population, but the evidence is disputed and few studies compare them with other people seen in sleep clinics. The authors compared deaths, hospital stays and emergency or urgent care visits in veterans with narcolepsy against a general sleep clinic group.

Who and how

Retrospective cohort study of nationwide Veterans Health Administration data from October 1999 through March 2025, using ICD-9/10 codes. Type 1 narcolepsy (NT1) required at least two NT1 codes. Two comparison groups were matched on age at index date, sex, race/ethnicity and diagnosis year: general sleep clinic patients without central hypersomnia codes (matched 1:3) and an 'other narcolepsy' group with narcolepsy codes but no NT1-specific code (matched 1:1). The primary outcome was all-cause mortality; secondary outcomes were hospitalization and emergency department/urgent care visits. Multivariable logistic regression adjusted for age, body mass index and Charlson Comorbidity Index.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The study included 4161 NT1, 4161 other narcolepsy and 12,843 general sleep clinic participants. Mean age was 48.0, 47.6 and 43.8 years, respectively.
  2. 2
    Deaths were more frequent in narcolepsy: 24.7% in NT1, 29.1% in other narcolepsy and 15.0% in the general sleep clinic group.
  3. 3
    After adjustment, the odds of death were higher than in the general sleep clinic group for NT1 (adjusted odds ratio 1.64, 95% CI 1.47-1.82) and for other narcolepsy (adjusted odds ratio 2.40, 95% CI 2.16-2.66).
  4. 4
    Hospitalization was higher only in NT1 (adjusted odds ratio 1.13, 95% CI 1.05-1.22).

Limits & uncertainty

  1. 1
    Participants were veterans referred for sleep evaluation, and the authors say generalizability to non-VA populations is uncertain.
  2. 2
    Diagnoses rely on billing codes, and the 'other narcolepsy' group is defined only by lacking NT1-specific codes.
  3. 3
    The groups differed in mean age despite matching, and the abstract reports no cause-specific deaths or modifiable risk factors.
  4. 4
    This reading is based on the abstract only.

What to take from it

People with narcolepsy may face higher mortality than other sleep clinic patients, which supports regular follow-up of overall health. The study cannot say why the deaths occurred or whether any change in care would lower the risk. Questions about narcolepsy care belong with a sleep clinician.

Reading your own data

Narcolepsy is diagnosed with clinical sleep testing, not wearable data, so there is nothing here to track yourself. If you have a diagnosis, a sleep diary or consistent device-based sleep timing can help you describe daytime sleepiness at appointments.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Importance

Prior research shows increased mortality in patients with narcolepsy compared to the general population; overall, the evidence remains highly controversial and comparative data with general sleep clinic populations remains limited.

Objective

We examined mortality and healthcare utilization among patients with narcolepsy compared to a general sleep clinic (GSC) cohort in the Veterans Affairs (VA) health system.

Design

Retrospective cohort study.

Setting

Nationwide Veterans Health Administration (VHA) data from October 1999 through March 2025.

Participants

The study used relevant ICD-9/10 codes. We defined narcolepsy 1 (NT1) as patients with at least two NT1 ICD-9/10 codes. We constructed two propensity-matched (on age at index date, sex, race/ethnicity, and diagnosis year) comparison groups: (i) General Sleep Clinic (GSC; with no central disorders of hypersomnia ICD codes), matched 1:3 and (ii) other narcolepsy (ON) group as patients with at least two narcolepsy ICD-9/10 codes but no NT1-specific codes, matched 1:1 to NT1 group.

Main outcomes and measures

The primary outcome was all-cause mortality. Secondary outcomes included all-cause hospitalization and emergency department/urgent care (ED/UC) visits. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression in the propensity score-matched cohorts, with GSC as the reference group and adjustment for age, body mass index, and Charlson Comorbidity Index.

Results

The cohort included 4161 NT1, 4161 ON, and 12,843 GSC participants. The mean age differed in the groups (48.0, 47.6, and 43.8 years for NT1, ON, and GSC, respectively). All-cause mortality was more frequent in NT1 and ON compared to GSC (24.7%, 29.1%, and 15.0% in NT1, ON, and GSC, respectively). Compared with GSC, aOR was higher in NT1 (aOR 1.64, 95% CI 1.47-1.82) and ON (aOR 2.40, 95% CI 2.16-2.66). In contrast, increased aOR of all-cause hospitalization was observed only in NT1 (aOR 1.13, 95% CI 1.05-1.22) compared to GSC.

Conclusions and relevance

Among veterans referred for sleep evaluation, adjusted OR of all-cause mortality was higher in narcolepsy patients compared to patients with other sleep disorders. The generalizability to non-VA populations remains uncertain. Future studies should identify cause-specific mortality and modifiable risk factors for prevention.

Key points

Question: In veterans referred for sleep evaluation, is narcolepsy associated with higher all-cause mortality than general sleep clinic patients?

Findings

In a retrospective propensity-matched cohort study of VA data (1999-2025) including 4161 NT1, 4161 other narcolepsy, and 12,843 general sleep clinic participants, mortality was 24.7%, 29.1%, and 15.0%; adjusted odds of mortality were significantly higher for NT1 (aOR 1.64) and other narcolepsy (aOR 2.40) vs. general sleep clinic. Meaning: These findings suggest elevated mortality risk in narcolepsy, highlighting the need for targeted prevention and risk-management strategies.

Sources & attribution

Mortality in narcolepsy and other sleep clinic patients: a 25-year propensity-matched VA cohort study.

Sharafkhaneh A, Dauvilliers Y, BaHammam AS, Azarian M, Thorpy M, Han F, Senel GB, Aksu M, Razjouyan J.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026-05-04

DOI: 10.1007/s44470-026-00078-8 ↗PubMed · 42082712 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

In-depth explainersRead study →
·Cohort study

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

In-depth explainersRead study →
·Randomised trial

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

In-depth explainersRead study →
·Cohort study

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

In-depth explainersRead study →
Sleep & circadian health →